publication venue for

• Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges 2025
• Cost Effectiveness of Point-of-Care HbA1c in Primary Care Setting in Brazil 2019
• Hypothalamic EphA5 facilitates counterregulatory responses: Possible role for bidirectional signaling leading to bistability that enhances responsiveness to hypoglycemia 2013
• Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys. 2012
• New diabetes diagnostic threshold of hemoglobin A 1c and the 3-year incidence of retinopathy 2012
• Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: Role of metabolic reprogramming in counterregulatory failure 2011
• Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia 2005
• Metabolic Pathways that Mediate Inhibition of Hypothalamic Neurons by Glucose 2004
• Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats 2003
• Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice 2003
• Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting 2001
• Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice 2000
• Hypothalamic glucose sensor: Similarities to and differences from pancreatic β-cell mechanisms 1999
• Erratum: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin (Diabetes (1998) 47 (294-297)) 1998
• Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin 1998
• Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. 1994
• Complications of pregnancy and fetal development. 1982